DMAC R&D to Revenue
Diamedica Therapeutics Inc · R&D to Revenue
DMAC R&D to Revenue
Latest reported0.00%period ending
DMAC FY R&D/Revenue (1363.58% → 0.00%)
Latest values, visible window
High-resolution chart · PNG
DMAC r&d to revenue history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 904.4% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 664.3986% | |
| 2,398.3254% | |
| 88.5977% | |
| 1,363.5843% |